Literature DB >> 20966029

Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.

Harshna Patel, E Jenny Heathcote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20966029     DOI： 10.1136/gut.2010.217323

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

Review 1.  Hepatitis in 2010: the dawn of a new era in HCV therapy.

Authors:  Sandra Ciesek; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

Review 2.  Novel therapies for hepatitis C - one pill fits all?

Authors:  Michael P Manns; Thomas von Hahn
Journal:  Nat Rev Drug Discov       Date:  2013-06-28       Impact factor: 84.694

Review 3.  Current progress in the treatment of chronic hepatitis C.

Authors:  Alexandra Alexopoulou; George V Papatheodoridis
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

4.  Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.

Authors:  Israr-Ul H Ansari; Todd Allen; Andrew Berical; Peter G Stock; Burc Barin; Rob Striker
Journal:  Virology       Date:  2013-01-02       Impact factor: 3.616

5.  Cellular growth kinetics distinguish a cyclophilin inhibitor from an HSP90 inhibitor as a selective inhibitor of hepatitis C virus.

Authors:  Rudolf K F Beran; Ruchi Sharma; Amoreena C Corsa; Yang Tian; Justin Golde; Greta Lundgaard; William E Delaney; Weidong Zhong; Andrew E Greenstein
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

Review 6.  Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals.

Authors:  Alexandra Alexopoulou; Peter Karayiannis
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

7.  Subtype specific differences in NS5A domain II reveals involvement of proline at position 310 in cyclosporine susceptibility of hepatitis C virus.

Authors:  Israr-ul H Ansari; Rob Striker
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.